---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-26-000005"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2026-01-02T23:59:59+00:00"
generated_at: "2026-05-16T11:48:48.127691+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Salarius receives Nasdaq delisting notice for bid price non-compliance; appeal planned

## Summary
- Nasdaq notified Salarius on Dec 31, 2025 that bid price closed below $1.00 for 30 consecutive days.
- Company ineligible for 180-day cure period due to reverse stock split within prior year.
- Unless appeal filed by Jan 7, 2026, trading suspended Jan 9, 2026 and Form 25-NSE filed.
- Salarius intends to appeal to Nasdaq Hearings Panel to stay suspension and present compliance plan.
- No assurance that securities will remain listed on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001615219-26-000005
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2026-01-02T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521926000005/0001615219-26-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521926000005/flks-20251231.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-26-000005
- JSON: https://secwatch.observer/filing/0001615219-26-000005.json
- Plain text: https://secwatch.observer/filing/0001615219-26-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.